Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Factor VIII

Concept
uri icon
  • Overview
scroll to property group menus

Overview

subject area of

  • 1-deamino-8-D-arginine vasopressin and cryoprecipitate in variant von Willebrand disease  Academic Article
  • 1-deamino-8-D-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases  Academic Article
  • A direct enzymatic assay for the esterolytic activity of activated hageman factor  Academic Article
  • A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A  Academic Article
  • Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis  Academic Article
  • Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor  Academic Article
  • Blood-coagulation factor Va abnormality associated with resistance to activated protein-C in venous thrombophilia  Academic Article
  • Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human Factor VIII/von Willebrand factor  Academic Article
  • Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease  Academic Article
  • Carbohydrate on human factor viii von willebrand factor - impairment of function by removal of specific galactose residues  Academic Article
  • Cathepsin g, a leukocyte protease, activates coagulation factorviii  Academic Article
  • Classification of variant von Willebrand's disease subtypes by analysis of functional characteristics and multimeric composition of factor VIII/von Willebrand factor  Academic Article
  • Clotting factors in von Willebrand's disease  Academic Article
  • Concentrates of clotting-factor IX  Academic Article
  • DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium  Academic Article
  • Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis  Academic Article
  • Development of factor VIII antibody in haemophilic monozygotic twins.  Academic Article
  • Differences between heterozygous dominant and recessive von Willebrand's disease type I expressed by bleeding symptoms and combinations of factor VIII variables  Academic Article
  • Drug-drug interaction of the anti-TFPI aptamer BAX499 and factor VIII: Studies of spatial dynamics of fibrin clot formation in hemophilia A  Academic Article
  • Enhanced factor VIII activity in von Willebrand's disease  Academic Article
  • Evidence of activation of the protein-c pathway during acute vascular damage induced by mediterranean spotted-fever  Academic Article
  • Factor VIII and chronic renal failure  Academic Article
  • Factor VIII antigen in the vessel walls in von Willebrand's disease and haemophilia A  Academic Article
  • Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities  Academic Article
  • Factor VIII-related properties in platelets from patients with von Willebrand's disease  Academic Article
  • Factor VIII/von Willebrand factor  Academic Article
  • Factor VIII/von Willebrand factor in glomerular nephropathies  Academic Article
  • Familial incidence of precipitating antibodies in von Willebrand's disease: A study of four cases  Academic Article
  • Formation of the fibrin clot: the balance of procoagulant and inhibitory factors  Academic Article
  • Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease  Academic Article
  • Homology models of the C domains of blood coagulation factors V and VIII: A proposed membrane binding mode for FV and FVIII C2 domains  Academic Article
  • Human protein-C and thromboembolic disease  Academic Article
  • Immunoradiometric assay of factor VIII related antigen, with observations in 32 patients with von Willebrand's disease  Academic Article
  • Inhibition of fibrinolysis by recombinant factor viia in plasma from patients with severe hemophilia a  Academic Article
  • Interaction of factor VIII antigen in hemophilic plasmas with human antibodies to factor VIII  Academic Article
  • Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants  Academic Article
  • Lymphocyte-instructed monocyte induction of the coagulation pathways parallels the induction of hepatitis by the murine hepatitis-virus  Academic Article
  • Mechanism of action of human activated protein-C, a thrombin-dependent anticoagulant enzyme  Academic Article
  • Molecular immunology of factor VIII  Academic Article
  • Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes  Academic Article
  • Nervous regulation of factor-VIII levels in man  Academic Article
  • Pathogenesis of von Willebrand's disease  Academic Article
  • Platelets and von Willebrand disease  Academic Article
  • Precipitating antibodies in von Willebrand's disease  Academic Article
  • Precipitating antibodies to factor VIII/von Willebrand factor in von Willebrand's disease: effects on replacement therapy  Academic Article
  • Preliminary trial of cyclophosphamide in the management of hemophiliacs with factor VIII inhibitors  Academic Article
  • Proteolytic inactivation of human factor-VIII procoagulant protein by activated human protein-C and its analogy with factor-V  Academic Article
  • Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex  Academic Article
  • Spectrum of von Willebrand's Disease: a study of 100 cases  Academic Article
  • Structural basis for hemophilia A caused by mutations in the C domains of blood coagulation factor VIII  Academic Article
  • Structure and function of von Willebrand factor: relationship to von Willebrand's disease  Academic Article
  • Studies on the prolonged bleeding time in von Willebrand's disease  Academic Article
  • The complex multimeric composition of factor VIII/von Willebrand factor  Academic Article
  • The defective down regulation of fibrinolysis in haemophilia a can be restored by increasing the tafi plasma concentration  Academic Article
  • The hematological aspects of a case of systemic lupus erythematosus  Academic Article
  • Thrombophilic factors are not the leading cause of thrombosis in Behcet's disease  Academic Article
  • Tissue distribution of factor VIII gene expression in vivo: a closer look  Academic Article
  • Type IIB Tampa: a variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates, and spontaneous platelet aggregation  Academic Article
  • Urinary excretion of factor VIII after renal transplantation  Academic Article
  • Urinary excretion of factor-VIII-related antigen and fibrin(ogen) degradation fragments D and E after kidney transplantation  Academic Article
  • Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets  Academic Article
  • Varied immunological reactivity of factor VIII from animal plasmas  Academic Article
  • Vascular remodeling underlies rebleeding in hemophilic arthropathy  Academic Article
  • [Factor VIII inhibitors][Article in Italian]  Academic Article
  • [Multimeric structure of factor VIII/von Willebrand factor released from human platelets by ADP, collagen and thrombin][Article in Spanish]  Academic Article
  • von Willebrand disease  Academic Article
  • von Willebrand factor  Academic Article
  • von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease  Academic Article
  • von Willebrand's Disease  Academic Article
  • von Willebrand's disease  Academic Article

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support